ELF4 and central nervous system cancer: Based on TCGA data, we found that gliomas with high ELF4 expression displayed elevated levels of both silent and non-silent mutation rates, SNV neoantigens, number of segments, fraction altered as well as aneuploidy score (Fig. 8A).